Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRent ExpenseResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Avricore Health (AVCRF) Investment Income (2024 - 2025)

Avricore Health has reported Investment Income over the past 2 years, most recently at $208.67 for Q4 2025.

  • Quarterly Investment Income rose 9616.76% to $208.67 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$68.83 through Dec 2025, changed N/A year-over-year, with the annual reading at -$66.56 for FY2025, 93.9% down from the prior year.
  • Investment Income was $208.67 for Q4 2025 at Avricore Health, up from $172.94 in the prior quarter.
  • Over five years, Investment Income peaked at $208.67 in Q4 2025 and troughed at -$493.65 in Q2 2025.